1. Sawai T, Inoue Y, Doi S, Izumikawa K, Ohno H, Yanagihara K, Higashiyama Y, Miyazaki Y, Hirakata Y, Tashiro T, Kohno S: A case of Mycobacterium nonchromogenicum pulmonary infection showing multiple nodular shadows in an immunocompetent patient. Diag Microbiol Infect Dis 54;311-314,2006
2. Miyazaki T, Miyazaki Y, Izumikawa K, Kakeya H, Miyakoshi S, John E. Bennett, Kohno S: Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance. Antimicrobial Agents Chemother 50;580-586,2006
3. Yanagihara K, Fukuda Y, Seki M, Izumikawa K, Higashiyama Y, Miyazaki Y, Hirakata Y, Tomono K, Mizuta Y, Tsukamoto K, Kohno S: Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia. Intern Med 45;995-999,2006
4. Seki M, Ikari N, Yamamoto S, Yamagata Y, Kosai K, Yanagihara K, Kakugawa T, Kurihara S, Izumikawa K, Miyazaki Y, Higashiyama Y, Hirakata Y, Tashiro T, Kohno S: Severe Japanese spotted fever successfully treated with fluoroquinolone. Intern Med 45;1323-1326,2006
5. Yanagihara K, Seki M, Izumikawa K, Higashiyama Y, Miyazaki Y, Hirakata Y, Tomono K, Mizuta Y, Tsukamoto K, Kohno S: Potency of DX-619, a novel des-F(6)-quinolone, in hematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-resistant Staphylococcus aureus. Int J Antimicrobiol Agents 28;212-216,2006
6. Izumikawa K, Morinaga Y, Izumikawa K, Hara K, Kohno S: A case of splenic abscess during treatment of interstitial pneumonia. J J Infect Dis 59;320-322,2006
7. Seki M, Hashiguchi K, Kosai K , Higashiyama Y, Yanagihara K, Kurihara S, Izumikawa K, Miyazaki Y, Tashiro T, Kohno S.A patient with fulminant primary influenza pneumonia which developed into secondary bacterial pneumonia. Acta Medica Nagasakiensia 51;121-124,2006
8. Miyazaki T, Tsai HF, Bennett JE. Kre29p is a novel nuclear protein involved in DNA repair and mitotic fidelity in Candida glabrata. Curr Genet 50;11-22:2006

(Presentations)

1. 6th International Society for Human and Animal Mycology Koichi Izumikawa, Tomomi Saijo, Masafumi Seki, Katunori Yanagihara, Yasuhito Higashiyama, Yoshitsugu Miyazaki, Yoichi Hirakata, Takayoshi Tashiro, & Shigeru Kohno: A TOF-mass based diagnosis for Aspergillus infection
2. 11th Congress of the Asian Pacific Society of Respirology Koichi Izumikawa: Modern treatment of RTI with moxifloxacin, a new respiratory quinolones
3. American Society for Microbiology 2006 International Conference Masafumi Seki, Yasuhito Higashiyama, Katsunori Yanagihara, Kosuke Kosai,  Koichi Izumikawa, Yoshitsugu Miyazaki, Yoichi Hirakata, Takayoshi Tashiro, and Shigeru Kohno: Severity and immune responses of pneumonia due to influenza virus and bacteria co-infection
4. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy Katsunori Yanagihara, Masafumi Seki, Koichi Izumikawa, Yoshitsugu Miyazaki, Yoichi Hirakata, Shimeru Kamihira and Shigeru Kohno: Efficacy of ME-1036 in MRSA and vancomycin-insensitive Staphylococcus aureus（VISA）hematogenous pulmonary infection model